Cantor Fitzgerald Weighs in on CRVS FY2026 Earnings
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Free Report) – Cantor Fitzgerald issued their FY2026 EPS estimates for shares of Corvus Pharmaceuticals in a report released on Monday, June 9th. Cantor Fitzgerald analyst L. Watsek forecasts that the company will earn ($0.62) per share for the year. The consensus estimate for Corvus Pharmaceuticals’ current full-year earnings is […]
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Free Report) – Cantor Fitzgerald issued their FY2026 EPS estimates for shares of Corvus Pharmaceuticals in a report released on Monday, June 9th. Cantor Fitzgerald analyst L. Watsek forecasts that the company will earn ($0.62) per share for the year. The consensus estimate for Corvus Pharmaceuticals’ current full-year earnings is […]
